Jane Street
CGON icon

Jane Street’s CG Oncology CGON Stock Holding History

Jane Street’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$210K Buy
+3,097
New +$175K ﹤0.01% 10034
2025
Q1 		– Sell
-61,362
Closed -$1.76M – 9536
2024
Q4 		$1.76M Sell
61,362
-134,589
-69% -$4.6M ﹤0.01% 4346
2024
Q3 		$7.39M Buy
195,951
+138,400
+240% +$4.85M ﹤0.01% 2278
2024
Q2 		$1.82M Sell
57,551
-18,802
-25% -$652K ﹤0.01% 4655
2024
Q1 		$3.35M Buy
+76,353
New +$3.12M ﹤0.01% 3221

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jane Street's CGON Position: Q1 2026 in Review

Jane Street opened a new position in CG Oncology (CGON) in Q1 2026: 3,097 shares worth $210K. The stake represents ﹤0.01% of the portfolio and ranks #10034 among its holdings. This is a return to the name: Jane Street previously reported a position in CGON as recently as Q4 2024.

Jane Street first reported a position in CGON in Q1 2024 and has held it in 5 quarters since. The position peaked at $7.39M in Q3 2024. 233 funds tracked by Wall St. Rank hold CGON as of Q1 2026.

  • Jane Street held 3,097 shares of CG Oncology worth $210K as of Q1 2026.
  • CG Oncology was a new Jane Street position in Q1 2026.
  • CG Oncology made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #10034 holding.
  • Jane Street first reported a position in CG Oncology in Q1 2024 and has held it in 5 quarters since.
  • Jane Street's CG Oncology position peaked at $7.39M in Q3 2024.
  • 233 funds tracked by Wall St. Rank held CG Oncology as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.